Evofem Biosciences EVFM
OTC EVFM
$0.01 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Evofem Biosciences (EVFM) Acquisitions (2018 - 2025)

Updated

Evofem Biosciences (EVFM) recorded Acquisitions of $57,000 in Q1 2025, up 23.9% from the prior quarter.

Analysis

Evofem Biosciences (EVFM) Acquisitions (2018 - 2025) Analysis & Trends

For FY2024, Evofem Biosciences reported Acquisitions of $555,000.

  • The Q1 2025 figure is the highest quarterly Acquisitions since Q1 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -17.15 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 11.21 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Evofem Biosciences 878,961.72 878,961.72 2.12 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 57,000.00
Dec 31, 2024 46,000.00
Mar 31, 2018 -1.90 Mn
API Access

Evofem Biosciences Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=EVFM&period=max&api_key=YOUR_API_KEY